Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anthracycline mechanisms in analogue selection.

E M Acton

    Drugs Under Experimental and Clinical Research
    |January 1, 1985
    PubMed
    Summary

    Simple mechanism-based tests aided the selection of three novel anthracycline analogues. These tests identified analogues with reduced cardiotoxicity and improved antitumour activity, suggesting a more effective approach to drug development.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Anticancer specificity of some ellipticinium salts against human brain tumors in vitro.

    Journal of medicinal chemistry·1994
    Same author

    Inhibition of nucleoside transport by nitrobenzylthioformycin analogs.

    Biochemical pharmacology·1990
    Same author

    Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein.

    The Journal of biological chemistry·1990
    Same author

    Neurotoxicity and dermatotoxicity of cyanomorpholinyl adriamycin.

    Cancer chemotherapy and pharmacology·1989
    Same author

    Effect of morpholinyladriamycin analogs and adriamycin on the activities of DNA polymerase alpha and RNA polymerase II of chicken leukemia cells.

    The Journal of pharmacology and experimental therapeutics·1987
    Same author

    N-(cyanomethyl)- and N-(2-methoxy-1-cyanoethyl)anthracyclines and related carboxyl derivatives.

    Journal of medicinal chemistry·1986

    Area of Science:

    • Pharmacology
    • Medicinal Chemistry
    • Drug Development

    Background:

    • Anthracyclines are a class of chemotherapy drugs used to treat various cancers.
    • Development of new anthracycline analogues aims to improve efficacy and reduce toxicity.
    • Understanding mechanisms of action is crucial for designing effective anticancer agents.

    Purpose of the Study:

    • To evaluate the utility of simple mechanism-based tests in selecting novel anthracycline analogues.
    • To characterize the antitumour activity and toxicity profiles of three new anthracycline analogues.
    • To explore the relationship between mechanisms of action and therapeutic outcomes.

    Main Methods:

    • Development and application of simple in vitro and in vivo assays to assess drug mechanisms.
    • Preclinical evaluation of three anthracycline analogues: 5-Iminodaunorubicin, N,N-Dibenzyldaunorubicin, and a cyanomorpholino derivative of doxorubicin.
    • Analysis of quinone redox cycling, metabolic activation, and antitumour potency.

    Main Results:

    • 5-Iminodaunorubicin showed suppressed quinone redox cycling, correlating with reduced cardiotoxicity but not antitumour activity.
    • N,N-Dibenzyldaunorubicin, an inactive prodrug, demonstrated improved activity possibly due to selective metabolic activation.
    • The cyanomorpholino derivative of doxorubicin exhibited potent and specific antitumour activity, suggesting a unique mechanism.

    Conclusions:

    • Simple tests focusing on mechanisms of action are effective for selecting promising anthracycline analogues.
    • Mechanism-based selection may be more efficient than extensive antitumour activity testing alone.
    • These findings support a targeted approach to developing next-generation anthracycline-based cancer therapies.

    Related Experiment Videos